McKesson Is Closing a $2.25 Billion Precision Medicine Group Deal
Photo: TokenPost
McKesson Corporation is closing a deal valued at about $2.25 billion for Precision Medicine Group. McKesson’s fiscal 2027 adjusted earnings per diluted share outlook stands at $45.60 to $46.40, up from $44.20 to $45.00 after second-quarter results. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
